Featuring a slide presentation and related discussion from Prof Rakesh Popat, including the following topics:
- Overview of GPRC5D in multiple myeloma (0:00)
- Key findings from the Phase I/II MonumenTAL-1 clinical trial (2:01)
- Key findings from the Phase III MonumenTAL-3 trial (5:50)
- Key findings from a Phase I study of arlocabtagene autoleucel and Phase II QUINTESSENTIAL study; ongoing Phase III QUINTESSENTIAL-3 study (8:51)
- Key findings from the Phase Ib/II RedirecTT-1 and Phase III MonumenTAL-6 study (13:29)
- Other GPRC5D treatments in development (16:44)
CME information and select publications